Crestor · DIN 02247163 · 20 mg · tablet
General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Savings card: innoviCares lists Crestor (Ontario list dated 2026-09-10) — pays part of the brand-versus-generic difference after other coverage; free sign-up. (innovicares.ca ↗)
Savings card: RxHelp ONE lists CRESTOR (read 2026-09-10) — brand-name savings card, free; cannot be combined with another card on the same claim. (rxhelp.ca ↗)
Limit of one Prescription Drug Card Program / Patient Financial Assistance Card from any adjudicator per DIN and claim submitted. The RxHelpONE card CANNOT be combined with any other card or offer. (Terms of Use) (rxhelp.ca, September 10, 2026 ↗)
1 brand, same coverage
Crestor · DIN 02247163
Manufacturer: AstraZeneca; listing date 2003-09-04
Health Canada: Marketed since 2003-02-19 · brand CRESTOR - 20MG · ATC C10AA07 ROSUVASTATIN · form Tablet · route Oral · ingredients ROSUVASTATIN (ROSUVASTATIN CALCIUM) 20 MG · company Astrazeneca canada inc · schedule Prescription
Ministry pays: $0.1692 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02247163)
Source record
DIN 02247163: Crestor
Raw flags: chronicUseMed=Y, sec3=Y
Item: 240600047; group id 308; item number 0676; lccId None; manufacturer id AZC
Source form: Tab; strength: 20mg
Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $2.0057; ministry $0.1692
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02247163
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=71405
Interchangeable products
Ach-Rosuvastatin · DIN 02438933 · $0.1692
Apo-Rosuvastatin · DIN 02337991 · $0.1692
Auro-Rosuvastatin · DIN 02442590 · $0.1692
Bio-Rosuvastatin · DIN 02444984 · $0.1692
Co Rosuvastatin · DIN 02339781 · $0.1692
Jamp Rosuvastatin Calcium · DIN 02498359 · $0.1692
Jamp-Rosuvastatin · DIN 02391279 · $0.1692
M-Rosuvastatin · DIN 02496550 · $0.1692
Mar-Rosuvastatin · DIN 02413086 · $0.1692
Med-Rosuvastatin · DIN 02399180 · $0.1692
Mint-Rosuvastatin · DIN 02397811 · $0.1692
NRA-Rosuvastatin · DIN 02477505 · $0.1692
NRA-Rosuvastatin Tablets · DIN 02536625 · $0.1692
PMS-Rosuvastatin · DIN 02378558 · $0.1692
PRZ-Rosuvastatin · DIN 02505592 · $0.1692
Rosuvastatin · DIN 02405644 · $0.1692
Rosuvastatin · DIN 02411644 · $0.1692
Sandoz Rosuvastatin · DIN 02338742 · $0.1692
Taro-Rosuvastatin · DIN 02382660 · $0.1692
Teva-Rosuvastatin · DIN 02354624 · $0.1692
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02247163
Shortage record checked October 6, 2026